Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0156 | 0.2184 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.1409 | 0.1395 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0111 | 0.5 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0024 | 0.0111 | 0.5 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0111 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0111 | 0.0096 |
Echinococcus granulosus | geminin | 0.0164 | 0.2313 | 0.1901 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0509 | 0.0494 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.2184 | 0.2172 |
Loa Loa (eye worm) | hypothetical protein | 0.0653 | 1 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0024 | 0.0111 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0018 | 0.0015 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0164 | 0.2313 | 0.1901 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0111 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0111 | 0.0096 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0018 | 0.0015 | 0.5 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.0653 | 1 | 1 |
Onchocerca volvulus | 0.0024 | 0.0111 | 0.5 | |
Schistosoma mansoni | hypothetical protein | 0.0164 | 0.2313 | 0.1901 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0024 | 0.0111 | 1 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.0653 | 1 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0.0111 | 0.5 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0024 | 0.0111 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0111 | 0.0096 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0024 | 0.0111 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0107 | 0.1409 | 0.626 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.0653 | 1 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0018 | 0.0015 | 0.139 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0024 | 0.0111 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0024 | 0.0111 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0156 | 0.2184 | 1 |
Echinococcus multilocularis | hormone sensitive lipase | 0.0653 | 1 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0049 | 0.0509 | 0.192 |
Echinococcus multilocularis | geminin | 0.0164 | 0.2313 | 0.1901 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0018 | 0.0015 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0156 | 0.2184 | 0.2172 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0024 | 0.0111 | 0.5 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0111 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0.0111 | 0.5 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0111 | 0.5 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0111 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0049 | 0.0509 | 0.192 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0024 | 0.0111 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0107 | 0.1409 | 0.0948 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0024 | 0.0111 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0049 | 0.0509 | 0.0494 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.